Bridging the Biomarker Chasm With Interprofessional Molecular Tumor Boards.
Jill M KolesarSusanne M ArnoldFrederick Rand UelandB Mark EversPublished in: JCO oncology practice (2023)
Molecular tumor boards including clinical pharmacists can overcome biomarker testing disparities.
Keyphrases